HISTORICAL FACTS: What to expect from quest diagnostics next quarterly earnings report - Caught on Camera

Valued at $20.6 billion by market cap, Secaucus, New Jersey-based Quest Diagnostics Incorporated (DGX) provides diagnostic testing services in the U.S. and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine, and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.

The healthcare major is gearing up to announce its third-quarter results before the market opens on Tuesday, Oct. 21. Ahead of the event, analysts expect DGX to deliver an adjusted profit of $2.51 per share, up 9.1% from $2.30 per share reported in the year-ago quarter. The company has a solid earnings surprise history. It has surpassed the Street’s bottom-line estimates in each of the past four quarters.